Abstract:In this paper, three kinds of hybrid carbonyl cobalt CO-releasing molecules (CORMs), RCOOCH2C2H [Co-2(CO)(6)] (R = NSAIDs-COOH, 1-11; R = celecoxib derivative-COOH, 15), RSO2(R') CH2C2H[Co-2(CO)(6)] (R = celecoxib, 12; R = nimesulide, 13) and ROCH2C2H[Co-2(CO)(6)] (R = ferulic acid etheyl ester, 14), were synthesized and characterized by IR, NMR and HRMS. The crystal structures of complexes 9, 11, 14 and 16 were determined by single-crystal X-ray diffraction. Meanwhile, the anti-tumor activity, protection on oxidative damage of H9c2 cells, anti-hypertension and myocardial protective effects were evaluated. The results showed only a part of the complexes had anticancer activity for the five cell lines compared with 5-FU. Among them, complexes 12 and 13 which modified by selective COX-2 inhibitors displayed strong antiproliferative activity and selectivity to MCF-7 cell and HT-29 cell lines, and their IC50 values were 33.6-55.8 mM; but compared with cis-platin (DDP), they showed slightly lower activities. The complex inhibited the expression of COX-2 in HT-29 cells and MCF-7 cells, and complex 12 had stronger inhibitory effects than the others, which was accordance with its stronger activity against cell proliferation. Secondly, the complex improved the survival rate of H9c2 cells injured by H2O2. For each tested complex, the survival rate increased obviously after the cells treated with H2O2 for 1h; but it increased slowly when the cells harmed for 8h due to the severe cell injury. In addition, the complexes displayed antihypertensive effects on spontaneously hypertensive rats, accompanying with good myocardium protection. This indicates these hybrid CORMs reduced myocardial toxicity of COX-2 inhibitors like, but there still has liver and kidney side-effects when administrating continuously for 14 days. (c) 2018 Elsevier B. V. All rights reserved.

Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis of Dihydropyrazole Sulphonamide Derivatives That Act As Anti-Cancer Agents Through COX-2 Inhibition

Synthesis and Biological Activities of Carbonyl Cobalt CORMs with Selectively Inhibiting Cyclooxygenase-2

Synthesis and Antitumor Activity of Scopoletin Derivatives

Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma

A Novel Myricetin Derivative with Anti-cancer Properties Induces Cell Cycle Arrest and Apoptosis in A549 Cells.

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirodihydrothiopyran-Oxindole Derivatives

Synthesis and Biological Evaluation of Sclareolide-Indole Conjugates and Their Derivatives

Design, Synthesis and Biological Evaluation of Pyridine Acyl Sulfonamide Derivatives As Novel COX-2 Inhibitors

Synthesis and antitumor activity of N-sulfonyl-3,7-dioxo-5β-cholan-24-amides, ursodeoxycholic acid derivatives.

An expedient multi‐component synthesis of pyridinyl‐spirooxindoles and their effect on proliferation of lung cancer A549 cells

Synthesis and biological evaluation of novel penindolone derivatives as potential antiproliferative agents against SCLC in vitro

Design and Biological Evaluation of Novel Hybrids of 1, 5-Diarylpyrazole and Chrysin for Selective COX-2 Inhibition.

Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation.

Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.

Synthesis and Biological Evaluation of 3-((1-Methyl-1H-pyrrol-2-yl)methylene)indolin-2-one Derivatives as Potent Anticancer Active Agents

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Synthesis and Evaluation of Novel Isoxazolyl Chalcones As Potential Anticancer Agents.

Design, Synthesis, and In vitro Biological Activities of Matrine Skeleton Derivatives as Potential Cancer Inhibitors